Under both Drake’s and Lynch’s types, the cost of deleterious mutations is exactly what drives mutation charges down (Drake 1991; Lynch 2010; Sung et al. 2012). hence, under both types, an increase in the common price of mutations would produce a reduce in mutation fees. To examine this, Drake examined mutation premiums of thermophiles and when